Myzotem 100mg Capsule

Myzotem 100mg Capsule contains the active ingredient temozolomide. It belongs to the class of medications known as Antitumor agents. It is prescribed to treat brain cancer, such as glioblastoma multiforme in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma in patients older than three years. Glioblastoma and anaplastic astrocytoma are the most common and aggressive brain cancers with low chances of survival. Anaplastic astrocytoma is treated with Myzotem 100mg Capsule or radiotherapy after biopsy, whereas Glioblastoma multiforme is treated with a combination of radiotherapy and Myzotem 100mg Capsule, and it is continued as maintenance therapy.

The common side effects that are likely to associate with Myzotem 100mg Capsule are nausea, vomiting, dizziness, diarrhea, constipation, hair loss, rashes, tiredness, frequent urination, vision and hearing problems, high blood sugar levels, muscle damage, pain in muscles and joints, memory loss, coordination problems, infections, sleep problems and loss of weight. Inform your doctor if any of these symptoms disturb you or persist.

Inform your physician if you are allergic to Myzotem 100mg Capsule and its ingredients. Before starting treatment with this medication, let your physician know if you have hepatitis B infection, anemia, low platelet count, low level of RBC and WBC, blood clotting problems, or any liver or kidney problems. Your physician will monitor your WBC and platelet counts regularly. Avoid taking this medication if you are pregnant or breastfeeding. Both women and men should use birth control to avoid pregnancy and fathering a child.